產品編號 | CAS號 | 項目名稱規格 | 分子式 | 加入購物車 |
---|---|---|---|---|
B804593 | 85116-37-6 | (-)-B-氯化二異松香芹硼烷, 60% in Heptane, ca. 1.7 mol/L, MkSeal (-)-B-Chlorodiisopinocampheylborane, 60% in Heptane, ca. 1.7 mol/L, MkSeal |
C20H34BCl | |
R859587 | 1429939-35-4 | (+)-1,13-雙[二(3,5-二甲基苯基)膦]-(5AR,8AR,14aR)-5a,6,7,8,8a,9-六氫-5-H-[1]苯并吡喃, 98%purity,99%e.e. 1,1'-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-Hexahydro-5H-[1]Benzopyrano[3,2-d]Xanthene-1,13-Diyl]Bis[1,1-di(3,5-Dimethylphenylphosphine, 98%purity,99%e.e. |
C52H54O2P2 | |
B906137 | 99135-95-2 | (+)-N-芐基-(3R,4R)-雙(二苯基膦)吡咯烷, 98% 1-Benzyl-3,4-(R,R)-bis(diphenylphosphino)pyrrolidine, 98% |
C35H33NP2 | |
B804592 | 112246-73-8 | (+)二異松蒎基氯硼烷, 60% in Heptane,ca. 1.7mol/L (+)-B-Chlorodiisopinocampheylborane, 60% in Heptane,ca. 1.7mol/L |
C20H34BCl | |
S859594 | 1439556-82-7 | (-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 98%purity,99%e.e. (S,S,S)-(-)-Ph-SKP, 98%purity,99%e.e. |
C44H38O2P2 | |
S859586 | 1429939-31-0 | (-)-1,13-Bis[di(3,5-dimethylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e. (S,S,S)-(-)-Xyl-SKP, 98%purity,99%e.e. |
C52H54O2P2 | |
S859613 | 1548897-80-8 | (-)-1,13-Bis[di(4-methylphenyl)phosphino]-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano[3,2-d]xanthene, 98%purity,99%e.e. (S,S,S)-(-)-Tol-SKP, 98%purity,99%e.e. |
C48H46O2P2 | |
S906113 | 1787246-78-9 | (-)-茚胺醇2,6-二乙基苯肼三氮唑, 97% (5aS,10bR)-2-(2,6-Diethylphenyl)-4,5a,6,10b-tetrahydro-2H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-11-ium tetrafluoroborate, 97% |
C22H24BF4N3O | |
R854260 | 1297613-73-0 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C37H27O4P | |
R854262 | 1297613-74-1 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C37H27O4P | |
R854269 | 1372719-93-1 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C45H31O4P | |
R854255 | 1297613-72-9 | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C29H23O4P | |
R853903 | 930784-57-9 | (11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98% (11aR)-10,11,12,13-Tetrahydro-N,N,3,7-tetramethyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98% |
C21H24NO2P | |
R853904 | 500997-69-3 | (11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e. (11aR)-10,11,12,13-Tetrahydro-N,N-bis[(1R)-1-phenylethyl]-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-amine, ≥98%,≥99% e.e. |
C33H32NO2P | |
R854400 | (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. |
C37H39O4P | ||
R854398 | (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e. (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥95%,≥99%e.e. |
C49H31O4P | ||
R854276 | 1801196-27-9 | (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-3,7-Bis(2,?4,?6-?trimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C35H35O4P | |
R854406 | (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. (11aR)-3,7-Bis(3,5-dichlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. |
C29H19Cl4O4P | ||
R854259 | 1297613-75-2 | (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,99%e.e. |
C33H31O4P | |
R854402 | (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, ≥98%,≥99%e.e. |
C31H21F6O4P |